Watch-and-wait policy versus rituximab-combined chemotherapy in Japanese patients with intestinal follicular lymphoma

Akira Tari, Yasuhiko Kitadai, Ritsuo Mouri, Hidehiko Takigawa, Hideki Asaoku, Keiichiro Mihara, Katsuyoshi Takata, Megumu Fujihara, Tadashi Yoshino, Tadashi Koga, Shunji Fujimori, Shinji Tanaka, Kazuaki Chayama

Research output: Contribution to journalArticlepeer-review

11 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Watch-and-wait policy versus rituximab-combined chemotherapy in Japanese patients with intestinal follicular lymphoma'. Together they form a unique fingerprint.

Medicine & Life Sciences